SuperworthPMV Pharmaceuticals market cap PMVP
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $67.9M
- Highest close in our data
- $2.8B
- Dec 2020
PMV Pharmaceuticals is worth $67.9M at the close on Oct 23, 2026, at $1.27 a share.
That is down 18% over the last year and down 94% over five years.
Its highest close in our data was $2.8B in Dec 2020.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $67.9M | $55.3M | $95.7M | +3% |
| 2025 | $66M | $45M | $82.7M | −15% |
| 2024 | $77.6M | $74.2M | $137.6M | −51% |
| 2023 | $158.6M | $59.6M | $432.7M | −60% |
| 2022 | $397.3M | $397.3M | $965.4M | −62% |
| 2021 | $1B | $1B | $2.1B | −62% |
| 2020 | $2.8B | $1.5B | $2.8B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest PMV Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| PMVPPMV Pharmaceuticals | $67.9M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| ATNMActinium Pharmaceuticals | $47.8M |
| NATRNatures Sunshine Products | $213.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| Peer median | $477.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on PMV Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.